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Abstract
Background: Not every individual exposed to Mycobacterium tuberculosis becomes infected. 
One host genetic factor, involved in modulating the immune response that has been studied in 
many ethnic groups is the association of human leukocyte antigens (HLA) with susceptibility to 
tuberculosis (TB).
Objective: To investigate the association between TB, HLA-DRB1 and HLA-DQB1 alleles in a 
Portuguese population.
Methods: HLA-DRB1 and HLA-DQB1 gene polymorphisms were analyzed by PCR-SSP in 92 TB 
patients, and 82 healthcare professionals without TB but exposed on a daily basis to infectious 
patients for more than two years (healthy exposed - HE). Tuberculin skin test reaction (TST), was 
positive in 69 individuals (all over 15 mm) in the HE group (HE+) and negative in thirteen (HE—).
Results: HLA-DRB1*14 frequency is higher in the TB patients group (7 % vs. 0; p = 0.038) than in HE+.
Conclusions: No genetic marker clearly indicative of disease susceptibility or resistance was 
identiÀ ed in this study. However, HLA-DRB1*14 was more frequent in TB patients suggesting that 
it may be involved in the evolution infection towards active TB in our population.
© 2009 Published by Elsevier España, S.L. on behalf of Sociedade Portuguesa de Pneumologia. 
All rights reserved.
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PALAVRAS-CHAVE
HLA;
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Resistência;
ProÀ ssionais de saúde
O papel do HLA classe II na susceptibilidade/resistência à tuberculose
Resumo
Introdução: Nem todos os indivíduos expostos ao Mycobacterium tuberculosis À cam infectados. 
Um dos factores genéticos envolvidos na modulação da resposta imune e estudado em muitos 
grupos étnicos é a associação entre moléculas HLA (human leukocyte antigens) e a 
susceptibilidade à tuberculose (TB).
Objectivo: Investigar a relação entre TB e os alelos HLA-DRB1, DQB1 numa população Portuguesa.
Métodos: Os polimorÀ smos dos genes HLA-DRB1 e HLA-DQB1 foram analisados por PCR-SSP em 
92 doentes com TB e 82 profissionais de saúde saudáveis, expostos diariamente a doentes 
baciliferos por um período superior a 2 anos (expostos saudáveis: ES). Neste grupo de ES, o teste 
tuberculínico foi positivo (TST ≥ 10 mm) em 69 indivíduos (todos com valor superior a 15 mm) 
(ES+) e negativo (TST < 10 mm) em 13 (ES—). Resultados: A frequência do alelo HLA-DRB1*14 é 
superior no grupo de doentes com tuberculose em relação ao grupo de ES+ (7 % vs. 0; p = 0,038).
Conclusões: Não foi identiÀ cado neste estudo, nenhum marcador genético de susceptibilidade/
resistência à doença. No entanto, o alelo HLA-DRB1*14 foi mais frequente nos doentes com 
tuberculose, sugerindo que possa estar envolvido na evolução da infecção para tuberculose 
activa na nossa população.
© 2009 Publicado por Elsevier España, S.L. em nome da Sociedade Portuguesa de Pneumologia. 
Todos os direitos reservados.
Introduction
Infection with Mycobacterium tuberculosis (MT) results in a 
variety of conditions ranging from asymptomatic infection to 
active tuberculosis (TB) with pulmonary or extrapulmonary 
involvement. In extreme cases MT infection may be fatal. 
One third of the World’s population is infected with MT; 1 
however, only a minority ever develop clinical disease. In 
90 % of infected individuals, bacilli remain under control in a 
latent state 2 (latent TB infection).
The various clinical features of TB result from cell-cell 
interactions that are promoted by cytokines produced by 
immune cells in response to MT infection. Studies of the 
diverse consequences of infection in twins 3 and under 
similar exposure conditions in a familial context 4 suggest the 
importance of genetics in susceptibility and/or resistance to 
TB. Several case-control studies have identiÀ ed associations 
between TB disease and gene polymorphisms. Among 
the candidate genes potentially involved in the immune 
response to TB are the murine natural resistance-associated 
macrophage protein 1 (NRAMP1) gene, 5 the vitamin D 
receptor (VDR) gene, 6-8 tumor necrosis factor alpha (TNFa, 9 
IL-10, 10-12 and IL-1. 13
HLA class II molecules are crucial in modulating the 
adaptative immune response, and their association with 
various diseases, including TB, has been described. However, 
results have been controversial concerning to TB, 14-20 with 
ethnic and/or geographic variations 21,22 apparently playing a 
major role in such discrepancies. The majority of published 
studies do not report MT exposure status in the control 
group and lack information about the role of HLA alleles and 
the outcome of TB infection.
In Portugal, the incidence of TB has been steadily 
decreasing since 1985, reaching a frequency of 25.3 per 
100,000 individuals in 2008 23 still higher than in the rest of 
the European Union. 24
Some hospitals were once TB sanatoriums, and for several 
years maintained an important tradition of inpatient TB 
treatment. Until recently, there were no special measures to 
prevent against nosocomial transmission, and well-equipped 
isolation rooms have only become available in the last 
decade. However, after having worked in an inpatient 
setting with high TB exposure and without special conditions 
during the sanatorium phase, most are disease-free and/or 
uninfected.
The aim of this study was to evaluate allelic associations 
with outcome of TB exposure, particularly in healthcare 
professionals heavily exposed to TB in the past, focusing 
on the importance of HLA-DRB1 and HLA-DQB1 alleles.
Methods
Subjects
All individuals were vaccinated with bacillus Calmette-Guerin 
(BCG) at birth, according to the national guidelines.
Patients
Ninety-two unrelated TB patients (33 women and 59 men) 
at the Pneumologic Diagnostic Center of Vila Nova de Gaia 
(CDP), Portugal, were studied. All had newly detected, 
active pulmonary TB diagnosed using standard clinical, 
radiographic and bacteriological criteria. The diagnosis of 
TB was conÀ rmed in all patients by positive sputum culture 
of M. tuberculosis (Table 1).
Healthy exposed
Eighty-two healthcare workers without active TB disease 
who had been exposed on a daily basis (for more than 8 hours 
a day in a confined environment) to infectious patients 
(inpatient and outpatient settings without protective 
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measures against nosocomial TB) for more than two years 
prior to 2000 were recruited (healthy exposed - HE). All 
were asymptomatic and presented normal pulmonary 
radiographies. Based on the results of tuberculin skin test 
(TST), 69 were found positive (HE+) and thirteen negative 
(HE—). HE+ positive results ranged from 15 to 20 mm.
Inclusion and exclusion criteria
Individuals belonging to any high-risk groups (e.g., 
drug users, sex workers, homeless) and persons with 
co-morbidities that would interfere with TST results or 
increased risk for TB, such as those with immunosuppressive 
disease (e.g., HIV infection, rheumatoid arthritis or cancer) 
or taking any immunosuppressive drug (e.g. corticosteroid) 
were excluded from the study.
Tuberculin skin test
Trained nursing staff from CDC administered TSTs (2-TU 
dose of puriÀ ed protein derivative RT23) according to the 
guidelines established by the Portuguese Pneumologic Society 
(SPP). 25 Briefly, 0.1 ml of the tuberculin purified protein 
derivative containing five tuberculin units was injected 
intradermally on the volar surface of individuals’ forearms. 
After 72 h, the diameter of the indurated area surrounding 
the injection site was measured and reported in millimeters. 
We considered 10 mm as the positive cut-off value.
HLA genotyping
Peripheral blood samples (10 ml) were collected in EDTA 
tubes. Genomic DNA was obtained from Proteinase-K 
treated peripheral blood leukocytes using a salting-out 
procedure. 26
DNA was amplified by polymerase chain reaction (PCR) 
using sequence-speciÀ c primers (PCR-SSP) for HLA-DRB1 and 
HLA-DQB1 genes, based on methods previously described. 27
PCR products were electrophoresed on 1.5 % agarose 
gels containing ethidium bromide, and visualized under 
ultraviolet light.
Statistical analysis
HLA-DRB1 and HLA-DQB1 phenotypic frequencies were 
determined by direct count. Comparisons of HLA frequencies 
between patients and controls were performed using the 
Pearson x 2 Test with continuity correction or the Fisher’s 
Exact Test when an expected absolute cell frequency was 
less than 5; p values ≤ 0.05 were considered statistically 
signiÀ cant, with relative risk deÀ ned using a 95 % conÀ dence 
interval (95 %CI). No multiple comparisons adjustments were 
considered in assigning values for signiÀ cant differences. 
All analyses were done with SPSS v.16 software (Statistical 
Product and Serve Solutions).
Results
HLA–DRB1 alleles
In the current study, there were no statistically signiÀ cant 
differences in the frequencies of HLA-DRB1 alleles between 
TB patients and the HE group (data not shown). When the HE 
group was stratiÀ ed for the presence of infection, however, 
we found that the HLA-DRB1*14 allele was absent in the 
HE+ group (0/6 cases) (7 % vs. 0; p = 0.038) (Table 2).
HLA–DQB1 alleles
There were no statistically significant differences in the 
frequencies of the distribution of HLA-DQB1 alleles in TB 
patients and the HE group.
The allele frequencies for normal healthy individuals (HC) 
were not substantially different from those reported in the 
same region. 28
Discussion
TB pathogenesis is very complex, with many factors 
influencing disease development and determining the 
outcome of infection. MT usually enters the body via 
the respiratory route. Phagocytosis of MT by alveolar 
macrophages is the first event in the host-pathogen 
interaction and may determine the outcome of infection. 
Table 1 Characteristics of TB patients, healthy-exposed 
individuals and healthy controls
Parameter TB patients 
(n = 92)
Healthy-exposed 
(n = 82)
Age
 Mean ± SD (years) 45,47 ± 15,40 42,57 ± 11,42
 Range 21-82 25-72
Gender
 Female 33 (36 %) 69 (84 %)
 Male 59 (64 %) 13 (16 %)
Positive TST  92 (100 %) 69 (75 %)
Table 2 HLA-DRB1* alleles phenotype frequency in TB 
patients and HE+ individuals
Alleles 
HLA-DRB1*
TB patients 
(n = 92)
HE+ 
(n = 69)
HE—
 n (%) n (%) p value n (%) p value
 1 21 (23) 16 (23) 3 (23)
 3 14 (15) 15 (22) 1 (8)
 4 27 (29) 15 (22) 3 (23)
 7 25 (27) 22 (32) 3 (23)
 8 13 (14) 7 (10) 1 (8)
 9 1 (1) 2 (3) 0 
10 5 (5) 1 (1) 1 (8) NS
11 15 (16) 16 (23) 4 (31)
12 0 3 (4) 0 
13 23 (25) 18 (26) 3 (23)
14 6 (7) 0 0.038 1 (8)
15 17 (18) 10 (14) 4 (31)
16 5 (5) 7 (10)  0  
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Within 2 to 6 weeks of infection, cell-mediated immunity 
is developed and an influx of lymphocytes and activated 
macrophages appears in the lesion, resulting in granuloma 
formation. The bacilli are contained in the granuloma, 
where they may remain forever (latent TB infection), or 
become re-activated at a later date to proliferate and 
ultimately evolve to an active disease state.
Not all individuals exposed to MT become infected. Of 
those who do become infected, the course and duration 
of progression to active disease are highly variable. This 
lack of uniformity in disease manifestation among infected 
individuals may reflect a complex interaction between 
genetic and environmental factors. The relative weight of 
some risk factors, such as AIDS, diabetes, family income 
and nutritional status, are known, but host genetic factors 
may also inÁ uence susceptibility to infection and disease 
pathogenesis. Despite the compelling rationale for the 
involvement of host genetic influences, evidence for a 
genetic basis for TB susceptibility has been difficult to 
establish.
Some candidate genes have been reported, 15-18 and a 
role for HLA, which is important in the immune response, 
has been recognized. In particular, a number of studies 
have reported an association between HLA Class II 
alleles and TB, but these associations are not consistent 
across different populations 15-18 and the results remain 
controversial. A study by Ruggiero et al showed an 
increase in HLA-DR4 frequency in an Italian population. 29 
A signiÀ cant increase in the frequency of HLA-DRB1*14 has 
been reported in Iranian patients, 30 an association that was 
conÀ rmed by Matrashkin et al in a Russian population. 31 A 
case-control study published by Dubaniewicz et al reported 
a strong association of HLA-DRB1*16 with TB in a Polish 
population. 32 More recently, this group confirmed and 
extended these results using a “high resolution” method, 
showing a high frequency of the HLA-DRB1*1601 allele 33 and 
a low frequency of HLA-DQB1*0201 in Polish TB patients; 
this latter result suggests that the HLA-DQB1*0201 allele 
may be linked to TB resistance. A high frequency of the 
HLA-DQB1*0501 allele has been reported among North 
American Indian 34 and Mexican 35 TB patients, whereas the 
frequency of the HLA-DQB1*0502 was increased among TB 
patients in a Thai population. 16 In a report from Cambodia, 
the HLA-DQB1*0503 allele was found to be associated with 
TB whereas the HLA-DQB1*0501 allele was not. 15 These 
differences are likely attributable to the differing ethnic 
backgrounds of the studied populations, but it should be 
stressed that some older studies used serological typing 
methods of dubious speciÀ city and sensitivity.
In this study we analyzed the distribution of HLA-DRB1 and 
HLA-DQB1 alleles in 92 TB patients and 82 disease-free 
healthcare professionals exposed to TB. The healthcare 
professionals chosen were from hospitals with a history of 
TB inpatient treatment and from ambulatory TB centers; 
only those individuals who had worked in these settings 
prior to 2000 were selected. Until very recently, there were 
no preventive measures against nosocomial TB in these 
settings except for individual protection. Most had worked 
in the same settings when the hospitals were sanatoria and 
exposure to TB was very high, a fact that explains the high 
prevalence of positive tuberculin skin test reactions (69/82) 
detected among these healthcare professionals.
There are two tests used in clinical practice to identify 
individuals with latent TB. These are the tuberculin skin 
test, and the interferon-gamma release assays (IGRAs), 
which identify a memory of an adaptive immune response 
against mycobacterial antigens. At the time this project was 
run, IGRAs were not widely available in our country so we 
could not use it.
The sensitivity of the tuberculin skin test is compromised 
in individuals with immunosuppression due to disease or 
treatment, but those were not studied here. The choice 
of TST cutpoint inÁ uences the probability that a positive 
TST reaction is a true positive due to M. tuberculosis 
versus a false positive, often due to cross-reactions from 
infection with nontuberculous mycobacteria (NTM), or 
BCG vaccination. But on the other side, NTM-induced 
TST reactions are generally in the 5 to 14-mm range. 36,37 
All exposed group who tested positive had reactions over 
15 mm which is very likely MT- induced
We found that the HLA-DRB1*14 allele frequency is higher 
among TB patients compared to HE+ group, suggesting that 
HLA-DRB1*14 could be a susceptibility allele for TB disease. 
Although the difference is relatively small, it is in agreement 
with previous reports from Iran and Russia, where this allele 
was found to be increased among TB patients. ConÀ rmation 
of these observations will require further study using larger 
groups of patients and healthy, TB-exposed individuals.
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